JPRN-jRCT2033210438进行中（未招募）1 期
Multicenter Trial of autologous nasal mucosal epithelial cell sheets for chronic middle ear inflammatory disease (middle ear cholesteatoma) - JMID01-01
Yamamoto Kazuhisa0 个研究点目标入组 12 人开始时间: 2021年11月22日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 < 75age old（—）
- 性别
- All
入选标准
- •1) Patients diagnosed with pars flaccida and pars tensa cholesteatoma and classified as Stage II or Stage III AO (adhesive otitis) according to the staging of middle ear cholesteatoma (2015).
- •2) Patients undergoing tympanoplasty with mastoidectomy. Patients who have undergone canal wall down without reconstruction, or mastoid obliteration are excluded.
- •3) Patients aged >=18 and <75 at the time of consent acquisition.
- •4) Patients who have received sufficient explanation in participating in this study, and then, with sufficient understanding, have received written consent from the patient's own free will.
- •5) Outpatients who can attend the clinic according to the study schedule.
排除标准
- •1) Congenital cholesteatoma; secondary cholesteatoma; Combination of pars flaccida and pars tensa cholesteatoma; unclassifiable type cholesteatoma.
- •2) Patients with a preoperative air density area in the mastoid cavity =>50 mm^2 in the temporal bone CT horizontal section.
- •3) Patients with obvious scarring of the nasal mucosa at the site making harvesting impossible.
- •4) Patients with contraindications to antibacterial agents or anesthetics used in this study.
- •5) Patients with hypersensitivity to penicillin, kanamycin, streptomycin, or amphotericin B antibiotics. Patients with a history of hypersensitivity to penicillin or aminoglycoside antibiotics.
- •6) Patients with a history of hypersensitivity to animals (bovine, mouse or pig).
- •7) Patients with less than 5 years history of malignancy or suspected of having malignancy.
- •8) Diabetic patients with poor glycemic control.
- •9) Patients in whom complications, etc. were observed in the transplanted ear of the investigational product or the entire body, and the investigator or subinvestigator judged it difficult to evaluate.
- •10) Pregnant women, breastfeeding women or patients who may be pregnant or patients who wish to become pregnant during the study period.
- •11) Patients who have participated in other clinical trials within 3 months prior to the transplantation of the investigational product, patients who have participated in other clinical trials, and patients who are scheduled to participate in other clinical trials while participating in this clinical trial.
- •12) Patients judged inappropriate for the study by the investigator or sub-investigator.
研究者
相似试验
已完成
不适用
Evaluation of efficacy of Double Nasal-Scope Mucosal Cutdown Biopsy using the transnasal endoscope corresponding to the high frequency in gastric submucosal tumor.Gastric submucosal tumorJPRN-UMIN000008600Kanazawa Medical University20
已完成
不适用
A clinical trial to study the effects of different types of interfaces placed over nose on the safety and efficacy of non invasive ventilation in immature babiesCTRI/2020/07/026324Institute of Post Graduate Medical Education and Research Department of Neonatology210
已完成
不适用
A Post-Market Clinical Follow-up Investigation to Verify Performance and Safety of Viiral®Nasal Spray in Subjects With Dry Nose SymptomsRhinitis SiccaNCT05264350Viiral Nordic AB84
已完成
不适用
A clinical trial for comparison of Nasal Photoplethysmography Pain Scale with the current commercialized Pain Scale in surgical patientsKCT0002723Asan Medical Center100
已完成
不适用
A randomised controlled trial of nasal constant positive airway pressure (NCPAP) as primary therapy for respiratory distress syndrome (RDS) in very pre-term infants.eonatal Diseases: RespiratoryNeonatal DiseasesRespiratoryISRCTN68552342Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)200